Yun Feng Li
Directeur Financier/CFO chez MABPHARM LIMITED
Fortune : - $ au 30/04/2024
Profil
Yun Feng Li is currently the CFO, Co-Secretary & Executive Director at Mabpharm Ltd.
He is also the Deputy General Manager at Taizhou Mabtech Pharmaceutical Co. Ltd.
and Taizhou Mabtech Biotechnology Ltd.
Mr. Li's former positions include Deputy General Manager at Shanghai Biomabs Pharmaceuticals Co., Ltd., General Manager at Shanghai Xingsheng Pharmaceutical Co., Ltd., and Deputy General Manager at Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
He also held the position of Deputy General Manager at Shanghai Zhangjiang Biotechnology Co. Ltd., Shanghai Sinomab Biotechnology Co. Ltd., and Shanghai National Engineering Research Center of Antibody Medi.
Mr. Li received his undergraduate degree from Nanjing Normal University in 1998.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MABPHARM LIMITED
-.--% | 30/06/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Yun Feng Li
| Sociétés | Poste | Début |
|---|---|---|
| MABPHARM LIMITED | Directeur Financier/CFO | 20/07/2018 |
| Taizhou Mabtech Biotechnology Ltd. | Corporate Officer/Principal | 01/03/2016 |
| Taizhou Mabtech Pharmaceutical Co. Ltd. | Directeur/Membre du Conseil | 01/08/2018 |
Anciens postes connus de Yun Feng Li
| Sociétés | Poste | Fin |
|---|---|---|
| Shanghai Sinomab Biotechnology Co. Ltd. | Corporate Officer/Principal | 01/08/2018 |
| Shanghai Biomabs Pharmaceuticals Co., Ltd. | Corporate Officer/Principal | 01/08/2018 |
| Shanghai Zhangjiang Biotechnology Co. Ltd. | Corporate Officer/Principal | 01/07/2017 |
Shanghai Xingsheng Pharmaceutical Co., Ltd.
 Shanghai Xingsheng Pharmaceutical Co., Ltd. Financial ConglomeratesFinance Shanghai Xingsheng Pharmaceutical Co., Ltd. engages in the investment and transfer of technologies. Its business includes research and development of biological products, genetic engineering products, Chinese and western medicines, and biochemical reagents. The company was founded on December 23, 1998 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 01/03/2016 |
| SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD | Corporate Officer/Principal | 01/11/2012 |
Formation de Yun Feng Li
| Nanjing Normal University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MABPHARM LIMITED | Commercial Services |
| SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD | Health Technology |
| Entreprise privées | 8 |
|---|---|
| Taizhou Mabtech Biotechnology Ltd. | |
| Taizhou Mabtech Pharmaceutical Co. Ltd. | |
| Shanghai National Engineering Research Center of Antibody Medi | |
Shanghai Xingsheng Pharmaceutical Co., Ltd.
Shanghai Xingsheng Pharmaceutical Co., Ltd. Financial ConglomeratesFinance Shanghai Xingsheng Pharmaceutical Co., Ltd. engages in the investment and transfer of technologies. Its business includes research and development of biological products, genetic engineering products, Chinese and western medicines, and biochemical reagents. The company was founded on December 23, 1998 and is headquartered in Shanghai, China. | Finance |
| Shanghai Zhangjiang Biotechnology Co. Ltd. | |
| Shanghai Biomabs Pharmaceuticals Co., Ltd. | |
| Shanghai Sinomab Biotechnology Co. Ltd. | |
| Shanghai Cp Guojian Pharmaceutical Co Ltd. |
